Patents by Inventor David Balya

David Balya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutical tools and methods for treating blindness
    Patent number: 10987404
    Abstract: The present invention relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: April 27, 2021
    Assignee: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
    Inventors: David Balya, Volker Busskamp, Pamela Lagali, Botond Roska
  • NOVEL THERAPEUTICAL TOOLS AND METHODS FOR TREATING BLINDNESS
    Publication number: 20180125925
    Abstract: The present invention relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Application
    Filed: November 13, 2017
    Publication date: May 10, 2018
    Applicant: FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH
    Inventors: David BALYA, Volker BUSSKAMP, Pamela LAGALI, Botond ROSKA
  • Therapeutical tools and methods for treating blindness
    Patent number: 9844579
    Abstract: The present inventions relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: December 19, 2017
    Assignee: Friedrich Miescher Institute for Biomedical Research
    Inventors: David Balya, Volker Busskamp, Pamela Lagali, Botond Roska
  • Novel Therapeutical Tools and Methods for Treating Blindness
    Publication number: 20120258530
    Abstract: The present inventions relates to the use of an isolated nucleic acid molecule comprising a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence complementary to said nucleotide sequence, for treating or ameliorating blindness. The light-gated ion channel or pump gene can be a halorhodopsin gene.
    Type: Application
    Filed: November 18, 2011
    Publication date: October 11, 2012
    Inventors: David BALYA, Rita HABAR, Volker BUSSKAMP, Pamela LAGALI, Botond ROSKA
  • Use of Light Sensitive Genes
    Publication number: 20090088399
    Abstract: The invention relates to the use of a light-gated ion channel for the manufacture of a medicament for the treatment of blindness and a method for expressing said cell specific fashion, e.g. in ON-bipolar cells, ON-ganglion cells, or AII amacrine cells.
    Type: Application
    Filed: August 21, 2007
    Publication date: April 2, 2009
    Inventors: David Balya, Pamela Sarita Lagali, Thomas Alexander Muench, Botond Roska